Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ASTS vs MRNA✓SelectedUSD · MRNAASTS vs MRNA performance historyLatest closeAs of-7.61%11/18
Stock and ETF performance explorer

ASTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+117.7%
MRNA return
-25.9%
Excess return
+143.5%
Maximum drawdown
-85.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-7.6%-4.8%-2.8%-6.9%
7D-30.4%-20.9%-9.5%-28.0%
30D-39.1%-13.3%-25.9%-37.9%
3M-62.0%+212.6%-274.6%-71.9%
6M-70.6%+309.0%-379.7%-80.3%
YTD-64.9%+567.3%-632.2%-80.2%
1Y-56.2%+689.7%-745.9%-76.5%
3Y+427.7%+157.4%+270.3%+255.0%
All+117.7%-25.9%+143.5%+75.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling